4.2 Article

Monoclonal anti-CD47 interference in red cell and platelet testing

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

A drug development perspective on targeting tumor-associated myeloid cells

Meher Majety et al.

FEBS JOURNAL (2018)

Review Oncology

Cancer immunotherapy targeting the CD47/SIRPα axis

Kipp Weiskopf

EUROPEAN JOURNAL OF CANCER (2017)

Letter Hematology

Daratumumab (anti-CD38) induces loss of CD38 on red blood cells

Harold C. Sullivan et al.

Article Biochemistry & Molecular Biology

CD47 blockade triggers T cell-mediated destruction of immunogenic tumors

Xiaojuan Liu et al.

NATURE MEDICINE (2015)

Article Hematology

Resolving the daratumumab interference with blood compatibility testing

Claudia I. Chapuy et al.

TRANSFUSION (2015)

Article Multidisciplinary Sciences

Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response

Diane Tseng et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Multidisciplinary Sciences

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

Stephen B. Willingham et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Biochemistry & Molecular Biology

CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis

Siddhartha Jaiswal et al.

Review Allergy

Monoclonal antibodies and fusion proteins in medicine

SNC Liossis et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)

Article Multidisciplinary Sciences

Role of CD47 as a marker of self on red blood cells

PA Oldenborg et al.

SCIENCE (2000)